How GNC Is Making Moves in the Age of Ozempic and Wegovy
GNC CEO, Michael Costello, joins Cheddar to discuss how the wellness business is evolving and what offerings they have similar to GLP-1 drugs. Watch!
More Videos
Trump Family Crypto Empire: A Web of Millions, Influence, and Ethical Concerns
Sam Blum, Senior Writer at Inc. Magazine, discusses one of his latest articles on why the Trump family is embracing crypto. Watch!
Real Assets Gain Traction in Bank of America's 2025 Specialty Asset Management Outlook
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health Raises Pharmaceutical Segment Profit Guidance 12-13% for FY25
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
Inside the CRE Market: Peachtree Group CEO Breaks Down Industry Trends
Peachtree CEO Greg Friedman on the hospitality business, commercial real estate and what the numbers are telling you. Watch!
Autonomous Ambitions: How Oshkosh is Steering Commercial Vehicles into the Future with AI
Oshkosh CEO John Pfeifer joins J.D. Durkin to discuss artificial intelligence, autonomy, and reinventing commercial vehicles. Watch!
Watch Cheddar News
Business, tech, innovation — Cheddar covers all of it with exclusive shows and thought-provoking interviews.
